Jupiter Neurosciences Receives Nasdaq Delisting Notice and Plans to Request Hearing

Filing content

Jupiter Neurosciences received a delisting notice from Nasdaq due to market value deficiency and intends to request a hearing before the Nasdaq Hearings Panel. The company has regained compliance with the minimum bid price requirement.